Rahnama’i, M. S.
Javan Balegh Marand, A.
Röschmann-Doose, K.
Steffens, L.
Arendsen, H. J.
Funding for this research was provided by:
G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany
Article History
Received: 15 July 2022
Accepted: 11 November 2022
First Online: 23 November 2022
Declarations
:
: This retrospective data analysis has been approved by the Ethics Committee at Alrijne Ziekenhuis Leiden, in accordance with the provisions of the Declaration of Helsinki. Patients were asked, whether they would agree to evaluation and publication of data obtained during their treatment for research purpose and gave informed consent electronically.
: Not applicable.
: M.S. Rahnama’i reports fees from Farco Pharma and G. Pohl-Boskamp. K. Röschmann-Doose is an employee of G. Pohl-Boskamp. L. Steffens is an employee of G. Pohl-Boskamp. A. Javan Balegh Marand reports no conflicts of interest. H.J. Arendsen reports fees from G. Pohl-Boskamp during the conduct of the study.